NeuBright, A Purified Allogeneic Cell Therapy Product for Treatment of Dry Age-related Macular Degeneration - Theodore Leng

10/9/2020; 16 minutes

Theodore Leng, MD, MS
Stanford University Recorded on 09/14/2020.
(#36325)

Links & Resources

More Programs With

Explore more in this series:
2020 CIRM Grantee Meeting
2020 CIRM Grantee Meeting

More from
The Stem Cell Channel

 
 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2020 Regents of the University of California. All right reserved. Terms and Conditions of Use.